Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8401 | 1188 | 43.1 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
382 | 16384 | LUNG CANCER//THORAC SURG//TRANSBRONCHIAL NEEDLE ASPIRATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SW MED SIMMONS CANC | Address | 6 | 80% | 0% | 4 |
2 | COPY NUMBER LOSS | Author keyword | 4 | 75% | 0% | 3 |
3 | K RAS GENOTYPES | Author keyword | 3 | 100% | 0% | 3 |
4 | CLIN SCI K4 666 | Address | 2 | 67% | 0% | 2 |
5 | HIGH LEVEL AMPLIFICATION | Author keyword | 2 | 67% | 0% | 2 |
6 | LUNG CANC BASIC PROGRAM | Address | 2 | 67% | 0% | 2 |
7 | NUTRIT BIOCHEM MOL BIOL | Address | 2 | 67% | 0% | 2 |
8 | ETIOL CHEM CARCINOGENESIS | Address | 1 | 100% | 0% | 2 |
9 | FRACTIONAL ALLELE LOSS | Author keyword | 1 | 50% | 0% | 2 |
10 | SOMATIC GENETIC CHANGES | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COPY NUMBER LOSS | 4 | 75% | 0% | 3 | Search COPY+NUMBER+LOSS | Search COPY+NUMBER+LOSS |
2 | K RAS GENOTYPES | 3 | 100% | 0% | 3 | Search K+RAS+GENOTYPES | Search K+RAS+GENOTYPES |
3 | HIGH LEVEL AMPLIFICATION | 2 | 67% | 0% | 2 | Search HIGH+LEVEL+AMPLIFICATION | Search HIGH+LEVEL+AMPLIFICATION |
4 | FRACTIONAL ALLELE LOSS | 1 | 50% | 0% | 2 | Search FRACTIONAL+ALLELE+LOSS | Search FRACTIONAL+ALLELE+LOSS |
5 | SOMATIC GENETIC CHANGES | 1 | 100% | 0% | 2 | Search SOMATIC+GENETIC+CHANGES | Search SOMATIC+GENETIC+CHANGES |
6 | ONCOPROTEINS | 1 | 11% | 1% | 11 | Search ONCOPROTEINS | Search ONCOPROTEINS |
7 | ENRICHED PCR | 1 | 30% | 0% | 3 | Search ENRICHED+PCR | Search ENRICHED+PCR |
8 | 5Q14 | 1 | 50% | 0% | 1 | Search 5Q14 | Search 5Q14 |
9 | 7P12 | 1 | 50% | 0% | 1 | Search 7P12 | Search 7P12 |
10 | AGGRESSIVENESS OF TUMORS | 1 | 50% | 0% | 1 | Search AGGRESSIVENESS+OF+TUMORS | Search AGGRESSIVENESS+OF+TUMORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SHORTENED SURVIVAL | 24 | 42% | 4% | 45 |
2 | K RAS ONCOGENE | 8 | 19% | 3% | 41 |
3 | RETINOBLASTOMA PROTEIN EXPRESSION | 7 | 27% | 2% | 23 |
4 | FORMER SMOKERS | 7 | 16% | 3% | 40 |
5 | FAMILY DNA AMPLIFICATION | 6 | 58% | 1% | 7 |
6 | ONCOGENE ACTIVATION | 6 | 12% | 4% | 45 |
7 | DNA GAINS | 5 | 60% | 1% | 6 |
8 | RAS ONCOGENE ACTIVATION | 5 | 17% | 2% | 27 |
9 | EARLY BRONCHIAL NEOPLASIA | 4 | 56% | 0% | 5 |
10 | CANCER PATIENTS TUMORS | 3 | 100% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis | 2001 | 197 | 105 | 56% |
Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: A review | 2005 | 159 | 111 | 36% |
The TP53 gene, tobacco exposure, and lung cancer | 2003 | 134 | 65 | 42% |
The international system for staging lung cancer | 2000 | 153 | 12 | 50% |
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation | 2006 | 104 | 182 | 26% |
TP53 Mutations in Nonsmall Cell Lung Cancer | 2011 | 28 | 88 | 27% |
Cytogenetic and molecular aspects of lung cancer | 2006 | 25 | 65 | 63% |
The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature | 2003 | 59 | 58 | 48% |
Meta-analyses of p53 tumor suppressor gene alterations and clinicopathological features in resected lung cancers | 1999 | 48 | 92 | 72% |
Molecular genetics of lung cancer | 2003 | 178 | 65 | 17% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SW MED SIMMONS CANC | 6 | 80% | 0.3% | 4 |
2 | CLIN SCI K4 666 | 2 | 67% | 0.2% | 2 |
3 | LUNG CANC BASIC PROGRAM | 2 | 67% | 0.2% | 2 |
4 | NUTRIT BIOCHEM MOL BIOL | 2 | 67% | 0.2% | 2 |
5 | ETIOL CHEM CARCINOGENESIS | 1 | 100% | 0.2% | 2 |
6 | SHANGHAI CLIN BIOINFORMAT | 1 | 33% | 0.3% | 3 |
7 | CRIT CARE THORAC ONCOL | 1 | 30% | 0.3% | 3 |
8 | INTERNAL MED ENDOCRINOL HAEMOSTAT DISORDER | 1 | 30% | 0.3% | 3 |
9 | ONCOL HEMATOL IMMUNOL | 1 | 40% | 0.2% | 2 |
10 | INVEST CLIN ONCOL EXPT HJ TAGNON | 1 | 22% | 0.3% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000184305 | RBM5//HUMAN CHROMOSOME 3//LUCA 15 |
2 | 0.0000182351 | AUTOFLUORESCENCE BRONCHOSCOPY//ROENTGENOGRAPHICALLY OCCULT LUNG CANCER//VIDEOBRONCHOSCOPY |
3 | 0.0000145928 | SMALL CELL LUNG CANCER CELL LINE//SMALL CELL LUNG CANCER CELL LINES//DRUG SCREENING ASSAY |
4 | 0.0000143383 | PHILIP MORRIS INT RD//COMPUTAT PL GENOM PROGRAM//SECT COMPUTAT BIOMED |
5 | 0.0000115901 | BRONCHIOLOALVEOLAR CARCINOMA//BRONCHORRHEA//ATYPICAL ADENOMATOUS HYPERPLASIA |
6 | 0.0000096770 | RASSF1A//RASSF2//RASSF1 |
7 | 0.0000088873 | L MYC//H RAS MINISATELLITE//L MYC POLYMORPHISM |
8 | 0.0000084212 | P53 GENE//P53 MUTANTS//MUTANT P53 |
9 | 0.0000076973 | LARGE CELL NEUROENDOCRINE CARCINOMA//TYPICAL CARCINOID//ATYPICAL CARCINOID |
10 | 0.0000075106 | METACHRONOUS LUNG CANCER//MULTIPLE PRIMARY LUNG CANCER//INTRAPULMONARY METASTASIS |